What a difference a dalton makes: Bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation

Microbiology and Molecular Biology Reviews

Volumn 77, Issue 3, 2013, Pages 527-539

  Washington, Erica J ^a   Banfield, Mark J ^c   Dangl, Jeffery L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ASPARAGINE; ASPARTIC ACID; BACTERIAL PROTEIN; BACTERIAL TOXIN; CYCLE INHIBITING FACTOR; CYSTEINE; CYTOTOXIC NECROTIZING FACTOR 1; GLUTAMIC ACID; GLUTAMINE; INITIATION FACTOR 4A; NEDD8 PROTEIN; PAPAIN; PROTEASOME; PROTEIN OSPL; PROTEIN VOPC; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME 13; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; BACTERIAL VIRULENCE; BURKHOLDERIA; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DEAMINATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EUKARYOTE; HOST; HOST CELL; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PASTEURELLA MULTOCIDA; PROTEIN FAMILY; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; VIBRIO PARAHAEMOLYTICUS;

ANIMALS; ASPARAGINASE; BACTERIAL PROTEINS; HUMANS; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

EID: 84884529039     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00013-13     Document Type: Review

References (86)

1. Cui J, Shao F. 2011. Biochemistry and cell signaling taught by bacterial effectors. Trends Biochem. Sci. 36:532-540.
2. Ribet D, Cossart P. 2010. Pathogen-mediated posttranslational modifications: a re-emerging field. Cell 143:694-702.
3. Yarbrough ML, Orth K. 2009. AMPylation is a new post-translational modiFICation. Nat. Chem. Biol. 5:378-379.
4. Robinson AB, Rudd CJ. 1974. Deamidation of glutaminyl and asparaginyl residues in peptides and proteins. Curr. Top. Cell. Regul. 8:247-295.
5. Chao X, Muff TJ, Park SY, Zhang S, Pollard AM, Ordal GW, Bilwes AM, Crane BR. 2006. A receptor-modifying deamidase in complex with a signaling phosphatase reveals reciprocal regulation. Cell 124:561-571. (Pubitemid 43199441)
6. Striebel F, Imkamp F, Sutter M, Steiner M, Mamedov A, Weber-Ban E. 2009. Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes. Nat. Struct. Mol. Biol. 16:647-651.
7. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387:729-733. (Pubitemid 27270616)
8. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. 1997. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387:725-729. (Pubitemid 27270615)
9. Doye A, Mettouchi A, Bossis G, Clement R, Buisson-Touati C, Flatau G, Gagnoux L, Piechaczyk M, Boquet P, Lemichez E. 2002. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 111:553-564. (Pubitemid 35356560)
10. Galan JE, Zhou D. 2000. Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc. Natl. Acad. Sci. U. S. A. 97:8754-8761. (Pubitemid 30626622)
11. Cruz-Migoni A, Hautbergue GM, Artymiuk PJ, Baker PJ, Bokori-Brown M, Chang CT, Dickman MJ, Essex-Lopresti A, Harding SV, Mahadi NM, Marshall LE, Mobbs GW, Mohamed R, Nathan S, Ngugi SA, Ong C, Ooi WF, Partridge LJ, Phillips HL, Raih MF, Ruzheinikov S, Sarkar-Tyson M, Sedelnikova SE, Smither SJ, Tan P, Titball RW, Wilson SA, Rice DW. 2011. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science 334:821-824.
12. Zhang L, Krachler AM, Broberg CA, Li Y, Mirzaei H, Gilpin CJ, Orth K. 2012. Type III effector VopC mediates invasion for Vibrio species. Cell Rep. 1:453-460.
13. Orth JH, Preuss I, Fester I, Schlosser A, Wilson BA, Aktories K. 2009. Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc. Natl. Acad. Sci. U. S. A. 106:7179-7184.
14. Cui J, Yao Q, Li S, Ding X, Lu Q, Mao H, Liu L, Zheng N, Chen S, Shao F. 2010. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329:1215-1218.
15. Sanada T, Kim M, Mimuro H, Suzuki M, Ogawa M, Oyama A, Ashida H, Kobayashi T, Koyama T, Nagai S, Shibata Y, Gohda J, Inoue J, Mizushima T, Sasakawa C. 2012. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483:623-626.
16. Caprioli AFV, Roda LG, Ruggeri FM, Zona C. 1983. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect. Immun. 39:1300-1306. (Pubitemid 13159977)
17. Oswald E, De Rycke J, Guillot JF, Boivin R. 1989. Cytotoxic effect of multinucleation in HeLa cell cultures associated with the presence of Vir plasmid in Escherichia coli strains. FEMS Microbiol. Lett. 49:95-99.
18. Orden JA, Dominguez-Bernal G, Martinez-Pulgarin S, Blanco M, Blanco JE, Mora A, Blanco J, Blanco J, de la Fuente R. 2007. Necrotoxigenic Escherichia coli from sheep and goats produce a new type of cytotoxic necrotizing factor (CNF3) associated with the eae and ehxA genes. Int. Microbiol. 10:47-55. (Pubitemid 46556858)
19. Lockman HA, Gillespie RA, Baker BD, Shakhnovich E. 2002. Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect. Immun. 70:2708-2714. (Pubitemid 34408421)
20. Schmidt G, Goehring UM, Schirmer J, Uttenweiler-Joseph S, Wilm M, Lohmann M, Giese A, Schmalzing G, Aktories K. 2001. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infect. Immun. 69:7663-7670. (Pubitemid 33086595)
21. Masuda M, Betancourt L, Matsuzawa T, Kashimoto T, Takao T, Shimonishi Y, Horiguchi Y. 2000. Activation of rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. EMBO J. 19:521-530. (Pubitemid 30093725)
22. Lerm M, Selzer J, Hoffmeyer A, Rapp UR, Aktories K, Schmidt G. 1999. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect. Immun. 67:496-503. (Pubitemid 29059179)
23. Sugai M, Hatazaki K, Mogami A, Ohta H, Peres SY, Herault F, Horiguchi Y, Masuda M, Ueno Y, Komatsuzawa H, Suginaka H, Oswald E. 1999. Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a Gln residue in the conserved G-3 domain of the Rho family and preferentially inhibits the GTPase activity of RhoA and Rac1. Infect. Immun. 67:6550-6557.
24. Stoll T, Markwirth G, Reipschlager S, Schmidt G. 2009. A new member of a growing toxin family- Escherichia coli cytotoxic necrotizing factor 3 (CNF3). Toxicon 54:745-753.
25. Hoffmann C, Pop M, Leemhuis J, Schirmer J, Aktories K, Schmidt G. 2004. The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. J. Biol. Chem. 279:16026-16032. (Pubitemid 38509292)
26. Heasman SJ, Ridley AJ. 2008. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9:690-701.
27. Nobes CD, Hall A. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62.
28. Ridley AJ, Hall A. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
29. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
30. Lemichez E, Flatau G, Bruzzone M, Boquet P, Gauthier M. 1997. Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Mol. Microbiol. 24:1061-1070. (Pubitemid 27286157)
31. Contamin S, Galmiche A, Doye A, Flatau G, Benmerah A, Boquet P. 2000. The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step. Mol. Biol. Cell 11:1775-1787. (Pubitemid 30307912)
32. Buetow L, Flatau G, Chiu K, Boquet P, Ghosh P. 2001. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat. Struct. Biol. 8:584-588. (Pubitemid 32613004)
33. Buetow L, Ghosh P. 2003. Structural elements required for deamidation of RhoA by cytotoxic necrotizing factor 1. Biochemistry 42:12784-12791. (Pubitemid 37385809)
34. Schmidt G, Selzer J, Lerm M, Aktories K. 1998. The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J. Biol. Chem. 273:13669-13674. (Pubitemid 28268413)
35. Flatau G, Landraud L, Boquet P, Bruzzone M, Munro P. 2000. Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain. Biochem. Biophys. Res. Commun. 267:588-592. (Pubitemid 30076842)
36. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
37. Broberg CA, Calder TJ, Orth K. 2011. Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect. 13:992-1001.
38. Felix R, Fleisch H, Frandsen PL. 1992. Effect of Pasteurella multocida toxin on bone resorption in vitro. Infect. Immun. 60:4984-4988.
39. Mushin R, Schoenbaum M. 1980. A strain of Pasteurella multocida associated with infections in rabbit colonies. Lab. Anim. 14:353-356. (Pubitemid 11221070)
40. Garcia VF. 1997. Animal bites and Pasteurella infections. Pediatr. Rev. 18:127-130.
41. Pullinger GD, Sowdhamini R, Lax AJ. 2001. Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect. Immun. 69:7839-7850. (Pubitemid 33086615)
42. Kamitani S, Kitadokoro K, Miyazawa M, Toshima H, Fukui A, Abe H, Miyake M, Horiguchi Y. 2010. Characterization of the membranetargeting C1 domain in Pasteurella multocida toxin. J. Biol. Chem. 285:25467-25475.
43. Kitadokoro K, Kamitani S, Miyazawa M, Hanajima-Ozawa M, Fukui A, Miyake M, Horiguchi Y. 2007. Crystal structures reveal a thiol proteaselike catalytic triad in the C-terminal region of Pasteurella multocida toxin. Proc. Natl. Acad. Sci. U. S. A. 104:5139-5144. (Pubitemid 47186189)
44. Ward PN, Miles AJ, Sumner IG, Thomas LH, Lax AJ. 1998. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue. Infect. Immun. 66:5636-5642. (Pubitemid 28531816)
45. Orth JH, Blocker D, Aktories K. 2003. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin. Biochemistry 42:4971-4977. (Pubitemid 36532050)
46. Hennig B, Orth J, Aktories K, Diener M. 2008. Anion secretion evoked by Pasteurella multocida toxin across rat colon. Eur. J. Pharmacol. 583:156-163.
47. Lacerda HM, Lax AJ, Rozengurt E. 1996. Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J. Biol. Chem. 271:439-445.
48. Orth JH, Aktories K, Kubatzky KF. 2007. Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin. J. Biol. Chem. 282:3050-3057. (Pubitemid 47084349)
49. i signaling by Pasteurella multocida toxin. J. Biol. Chem. 283:23288-23294.
50. q and Gα12/13. J. Biol. Chem. 280:36701-36707. (Pubitemid 41587748)
51. Preuss I, Kurig B, Nurnberg B, Orth JH, Aktories K. 2009. Pasteurella multocida toxin activates GGβγ dimers of heterotrimeric G proteins. Cell. Signal. 21:551-558.
52. Staddon JM, Chanter N, Lax AJ, Higgins TE, Rozengurt E. 1990. Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J. Biol. Chem. 265:11841-11848.
53. q/11-selective inhibitor. J. Biol. Chem. 279:47438-47445.
54. Thomas W, Pullinger GD, Lax AJ, Rozengurt E. 2001. Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association. Infect. Immun. 69:5931-5935. (Pubitemid 32786538)
55. Wilson BA, Zhu X, Ho M, Lu L. 1997. Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G-q-coupled phospholipase C-1. J. Biol. Chem. 272:1268-1275. (Pubitemid 27034627)
56. Zywietz A, Gohla A, Schmelz M, Schultz G, Offermanns S. 2001. Pleiotropic effects of Pasteurella multocida toxin are mediated by Gqdependent and -independent mechanisms. Involvement of Gq but not G11. J. Biol. Chem. 276:3840-3845.
57. q. J. Biol. Chem. 279:34150-34155. (Pubitemid 39318037)
58. Orth JH, Fester I, Siegert P, Weise M, Lanner U, Kamitani S, Tachibana T, Wilson BA, Schlosser A, Horiguchi Y, Aktories K. 2013. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins. FASEB J. 27:832-842.
59. Kamitani S, Ao S, Toshima H, Tachibana T, Hashimoto M, Kitadokoro K, Fukui-Miyazaki A, Abe H, Horiguchi Y. 2011. Enzymatic actions of Pasteurella multocida toxin detected by monoclonal antibodies recognizing the deamidated α subunit of the heterotrimeric GTPase Gq. FEBS J. 278:2702-2712.
60. Croxen MA, Finlay BB. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38.
61. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140. (Pubitemid 39490066)
62. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 92:1664-1668.
63. Dean P, Kenny B. 2009. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr. Opin. Microbiol. 12:101-109.
64. Marches O, Ledger TN, Boury M, Ohara M, Tu X, Goffaux F, Mainil J, Rosenshine I, Sugai M, De Rycke J, Oswald E. 2003. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol. Microbiol. 50:1553-1567. (Pubitemid 38010452)
65. Jubelin G, Chavez CV, Taieb F, Banfield MJ, Samba-Louaka A, Nobe R, Nougayrede JP, Zumbihl R, Givaudan A, Escoubas JM, Oswald E. 2009. Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One 4:e4855. doi:10.1371/journal.pone.0004855.
66. Yao Q, Cui J, Zhu Y, Wang G, Hu L, Long C, Cao R, Liu X, Huang N, Chen S, Liu L, Shao F. 2009. A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc. Natl. Acad. Sci. U. S. A. 106:3716-3721.
67. Jubelin G, Taieb F, Duda DM, Hsu Y, Samba-Louaka A, Nobe R, Penary M, Watrin C, Nougayrede JP, Schulman BA, Stebbins CE, Oswald E. 2010. Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog. 6:e1001128. doi:10.1371 /journal.ppat.1001128.
68. Morikawa H, Kim M, Mimuro H, Punginelli C, Koyama T, Nagai S, Miyawaki A, Iwai K, Sasakawa C. 2010. The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of Cullin1. Biochem. Biophys. Res. Commun. 401:268-274.
69. Wei N, Serino G, Deng XW. 2008. The COP9 signalosome: more than a protease. Trends Biochem. Sci. 33:592-600.
70. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. 2008. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134:995-1006.
71. Yao Q, Cui J, Wang J, Li T, Wan X, Luo T, Gong YN, Xu Y, Huang N, Shao F. 2012. Structural mechanism of ubiquitin and NEDD8 deamidation catalyzed by bacterial effectors that induce macrophage-specific apoptosis. Proc. Natl. Acad. Sci. U. S. A. 109:20395-20400.
72. Boh BK, Ng MY, Leck YC, Shaw B, Long J, Sun GW, Gan YH, Searle MS, Layfield R, Hagen T. 2011. Inhibition of cullin RING ligases by cycle inhibiting factor: evidence for interference with Nedd8-induced conformational control. J. Mol. Biol. 413:430-437.
73. Toro TB, Toth JI, Petroski MD. 2013. The cyclomodulin cycle inhibiting factor (CIF) alters cullin neddylation dynamics. J. Biol. Chem. 288:14716-14726.
74. Taieb F, Nougayrede JP, Watrin C, Samba-Louaka A, Oswald E. 2006. Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. Cell. Microbiol. 8:1910-1921. (Pubitemid 44680873)
75. Samba-Louaka A, Nougayrede JP, Watrin C, Jubelin G, Oswald E, Taieb F. 2008. Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell. Microbiol. 10:2496-2508.
76. Crow A, Race PR, Jubelin G, Varela Chavez C, Escoubas JM, Oswald E, Banfield MJ. 2009. Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei. PLoS One 4:e5582. doi:10.1371/journal.pone.0005582.
77. Hsu Y, Jubelin G, Taieb F, Nougayrede JP, Oswald E, Stebbins CE. 2008. Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J. Mol. Biol. 384:465-477.
78. Crow A, Hughes RK, Taieb F, Oswald E, Banfield MJ. 2012. The molecular basis of ubiquitin-like protein NEDD8 deamidation by the bacterial effector protein Cif. Proc. Natl. Acad. Sci. U. S. A. 109:E1830-E1838.
79. Schroeder GN, Hilbi H. 2008. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 21:134-156. (Pubitemid 351160013)
80. Dupont N, Lacas-Gervais S, Bertout J, Paz I, Freche B, Van Nhieu GT, van der Goot FG, Sansonetti PJ, Lafont F. 2009. Shigella phagocytic vacuolar membrane remnants participate in the cellular response to pathogen invasion and are regulated by autophagy. Cell Host Microbe 6:137-149.
81. Rawlings DJ, Sommer K, Moreno-Garcia ME. 2006. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6:799-812. (Pubitemid 44631649)
82. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820.
83. Shao F, Merritt PM, Bao Z, Innes RW, Dixon JE. 2002. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 109:575-588. (Pubitemid 34628721)
84. Zhu M, Shao F, Innes RW, Dixon JE, Xu Z. 2004. The crystal structure of Pseudomonas avirulence protein AvrPphB: a papain-like fold with a distinct substrate-binding site. Proc. Natl. Acad. Sci. U. S. A. 101:302-307. (Pubitemid 38084245)
85. Fu P, Zhang X, Jin M, Xu L, Wang C, Xia Z, Zhu Y. 2013. Complex structure of OspI and Ubc13: the molecular basis of Ubc13 deamidation and convergence of bacterial and host E2 recognition. PLoS Pathog. 9:e1003322. doi:10.1371/journal. ppat.1003322.
86. Storer AC, Menard R. 1994. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 244:486-500.